Brief: MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
06/06/2024 13:40
June 6 (Reuters) - Mangoceuticals Inc MGRX.O :
* MANGORX RECEIVES NOTICE OF ACCEPTANCE FOR PATENT
APPLICATION IN
AUSTRALIA FOR RESPIRATORY ILLNESS AND PREVENTIVE CARE TECHNOLOGY
Source text for Eikon: ID:nGNX6n7jT
Further company coverage: MGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM